Molecular mechanisms of RET‐induced Hirschsprung pathogenesis

References

• Chakravarti A., Lyonnet S. Hirschsprung Disease. The Metabolic & Molecular Bases of Inherited Disease, Eighth International Edition, C. R Scriver, A. L Beaudet, D Valle, W. S Sly, B Childs, K. W Kinzler, editors, et al. McGraw‐Hill, New York 2001; vol. IV: p 6231–55, In
   Google Scholar
• Badner J. A., Sieber W. K., Garver K. L., Chakravarti A. A genetic study of Hirschsprung disease. Am J Hum Genet 1990; 46: 568–80
   PubMed Web of Science ®Google Scholar
• Martucciello G., Bicocchi M. P., Dodero P., Lerone M., Cirillo M. S., Puliti A., et al. Total colonic aganglionosis associated with interstitial deletion of the long arm of chromosome 10. Pediatr Surg Int 1992; 7: 308–10
   Google Scholar
• Luo Y., Ceccherini I., Pasini B., Matera I., Bicocchi M. P., Barone V., et al. Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease. Hum Mol Genet 1993; 2: 1803–08
   PubMedGoogle Scholar
• Fewtrell M. S., Tam P. K., Thomson A. H., Fitchett M., Currie J., Huson S. M., et al. Hirschsprung's disease associated with a deletion of chromosome 10 (q11.2q21.2): a further link with the neurocristopathies?. J Med Genet 1994; 31: 325–7
   Google Scholar
• Mulligan L. M., Kwok J. B., Healey C. S., Elsdon M. J., Eng C., Gardner E., et al. Germ‐line mutations of the RET proto‐oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458–60
   PubMed Web of Science ®Google Scholar
• Donis‐Keller H., Dou S., Chi D., Carlson K. M., Toshima K., Lairmore T. C., et al. Mutations in the RET proto‐oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993; 2: 851–6
   PubMed Web of Science ®Google Scholar
• Takahashi M., Ritz J., Cooper G. M. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 1985; 42: 581–8
   PubMed Web of Science ®Google Scholar
• Ceccherini I., Bocciardi R., Luo Y., Pasini B., Hofstra R., Takahashi M., et al. Exon structure and flanking intronic sequences of the human RET proto‐oncogene. Biochem Biophys Res Commun 1993; 196: 1288–95
   Google Scholar
• Myers S. M., Eng C., Ponder B. A., Mulligan L. M. Characterization of RET proto‐oncogene 3' splicing variants and polyadenylation sites: a novel C‐terminus for RET. Oncogene 1995; 11: 2039–45
   PubMed Web of Science ®Google Scholar
• De Graaf E., Sriniva S., Kilknny C., D'Agati V., Mankoo B., Costantini F., et al. Differential activities of the RET tyrosine ‐kinase recptor isoforms during mammmalian embryogenesis. Genes Dev 2001; 15: 2433–44
   Google Scholar
• Scott R. P., Eketjall S., Aineskog H., Ibanez C. F. Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase. J Biol Chem 2005; 280: 13442–9
   PubMedGoogle Scholar
• Anders J., Kjar S., Ibanez C. F. Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin‐like domains and a calcium‐binding site. J Biol Chem 2001; 276: 35808–17
   PubMed Web of Science ®Google Scholar
• Airaksinen M. S., Titievsky A., Saarma M. GDNF family neurotrophic factor signaling: four masters, one servant?. Mol Cell Neurosci 1999; 13: 313–25, Review
   PubMed Web of Science ®Google Scholar
• Arighi E., Borrello M. G., Sariola H. RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev 2005; 16: 441–67
   PubMed Web of Science ®Google Scholar
• Angrist M., Bolk S., Thiel B., Puffenberger E. G., Hofstra R. M., Buys C. H., et al. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 1995; 4: 821–30
   PubMed Web of Science ®Google Scholar
• Attie T., Pelet A., Edery P., Eng C., Mulligan L. M., Amiel J., et al. Diversity of RET proto‐oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 1995; 4: 1381–6
   PubMed Web of Science ®Google Scholar
• Seri M., Yin L., Barone V., Bolino A., Celli I., Bocciardi R., et al. Frequency of RET mutations in long‐ and short‐segment Hirschsprung disease. Hum Mutat 1997; 9: 243–9
   PubMed Web of Science ®Google Scholar
• Kashuk C. S., Stone E. A., Grice E. A., Portnoy M. E., Green E. D., Sidow A., et al. Phenotype‐genotype correlation in Hirschsprung disease is illuminated by comparative analysis of the RET protein sequence. Proc Natl Acad Sci U S A 2005; 102: 8949–54
   Google Scholar
• Pasini B., Borrello M. G., Greco A., Bongarzone I., Luo Y., Mondellini P., et al. Loss of function effect of RET mutations causing Hirschsprung disease. Nat Genet 1995; 10: 35–40
   PubMed Web of Science ®Google Scholar
• Carlomagno F., De Vita G., Berlingieri M. T., de Franciscis V., Melillo R. M., Colantuoni V., et al. Molecular heterogeneity of RET loss of function in Hirschsprung's disease. EMBO J 1996; 15: 2717–25
   PubMed Web of Science ®Google Scholar
• Pelet A., Geneste O., Edery P., Pasini A., Chappuis S., Atti T., et al. Various mechanisms cause RET‐mediated signaling defects in Hirschsprung's disease. J Clin Invest 1998; 101: 1415–23
   PubMedGoogle Scholar
• Geneste O., Bidaud C., De Vita G., Hofstra R. M., Tartare‐Deckert S., Buys C. H., et al. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site. Hum Mol Genet 1999; 8: 1989–99
   PubMedGoogle Scholar
• Asai N., Iwashita T., Matsuyama M., Takahashi M. Mechanism of activation of the ret proto‐oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 1995; 15: 1613–9
   PubMed Web of Science ®Google Scholar
• Iwashita T., Murakami H., Asai N., Takahashi M. Mechanism of ret dysfunction by Hirschsprung mutations affecting its extracellular domain. Hum Mol Genet 1996; 5: 1577–80
   PubMedGoogle Scholar
• Cosma M. P., Cardone M., Carlomagno F., Colantuoni V. Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism. Mol Cell Biol 1998; 18: 3321–9
   PubMedGoogle Scholar
• Kjaer S., Ibanez C. F. Intrinsic susceptibility to misfolding of a hot‐spot for Hirschsprung disease mutations in the ectodomain of RET. Hum Mol Genet 2003; 12: 2133–44
   PubMedGoogle Scholar
• Bordeaux M. C., Forcet C., Granger L., Corset V., Bidaud C., Billaud M., et al. The RET proto‐oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J 2000; 19: 4056–63
   PubMed Web of Science ®Google Scholar
• Eng C., Clayton D., Schuffenecker I., Lenoir G., Cote G., Gagel R. F., et al. The relationship between specific RET proto‐oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996; 276: 1575–9
   PubMed Web of Science ®Google Scholar
• Carlomagno F., Salvatore G., Cirafici A. M., De Vita G., Melillo R. M., de Franciscis V., et al. The different RET‐activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. Cancer Res 1997; 57: 391–5
   PubMedGoogle Scholar
• Takahashi M., Iwashita T., Santoro M., Lyonnet S., Lenoir G. M., Billaud M. Co‐segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss‐of‐function?. Hum Mutat 1999; 13: 331–6
   PubMedGoogle Scholar
• Mograbi B., Bocciardi R., Bourget I., Juhel T., Farahi‐Far D., Romeo G., et al. The sensitivity of activated Cys Ret mutants to glial cell line‐derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis. Mol Cell Biol 2001; 21: 6719–30
   PubMedGoogle Scholar
• Arighi E., Popsueva A., Degl'Innocenti D., Borrello M. G., Carniti C., Perala N. M., et al. Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease. Mol Endocrinol 2004; 18: 1004–17
   Google Scholar
• Decker R. A., Peacock M. L., Watson P. Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype‐phenotype correlation. Hum Mol Genet 1998; 7: 129–34
   PubMedGoogle Scholar
• Cartegni L., Chew S. L., Krainer A. R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 3: 285–98
   PubMed Web of Science ®Google Scholar
• Griseri P., Mishto M., Priolo M., Pesce B., Hamel B. J., Ravazzolo R., et al. An intronic nucleotide variant of the RET proto‐oncogene causes Hirschsprung disease by interfering with RNA splicing. Gene Funct Dis 2000; 5‐6: 184–8
   Google Scholar
• Auricchio A., Griseri P., Carpentieri M. L., Betsos N., Staiano A., Tozzi A., et al. Double Heterozygosity for a RET Substitution Interfering with Splicing and an EDNRB Missense Mutation in Hirschsprung Disease. Am J Hum Genet 1999; 64: 1216–21
   Google Scholar
• Bolk S., Pelet A., Hofstra R. M., Angrist M., Salomon R., Croaker D., et al. A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci U S A 2000; 97: 268–73
   PubMed Web of Science ®Google Scholar
• Borrego S., Saez M. E., Ruiz A., Gimm O., Lopez‐Alonso M., Antinolo G., et al. Specific polymorphisms in the RET proto‐oncogene are over‐represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. J Med Genet 1999; 36: 771–4
   PubMedGoogle Scholar
• Griseri P., Sancandi M., Patrone G., Bocciardi R., Hofstra R., Ravazzolo R., et al. A single‐nucleotide polymorphic variant of the RET proto‐oncogene is underrepresented in sporadic Hirschsprung disease. Eur J Hum Genet 2000; 8: 721–4
   PubMedGoogle Scholar
• Fitze G., Cramer J., Ziegler A., Schierz M., Schreiber M., Kuhlisch E., et al. Association between c135G/A genotype and RET proto‐oncogene germline mutations and phenotype of Hirschsprung's disease. Lancet 2002; 359: 1200–5
   Google Scholar
• Borrego S., Ruiz A., Saez M. E., Gimm O., Gao X., Lopez‐Alonso M., et al. RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease. J Med Genet 2000; 37: 572–8
   Google Scholar
• Carrasquillo M. M., McCallion A. S., Puffenberger E. G., Kashuk C. S., Nouri N., Chakravarti A. Genome‐wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet 2002; 32: 237–44
   PubMed Web of Science ®Google Scholar
• Fitze G., Appelt H., Konig I. R., Gorgens H., Stein U., Walther W., et al. Functional haplotypes of the RET proto‐oncogene promoter are associated with Hirschsprung disease (HSCR). Hum Mol Genet 2003; 12: 3207–14
   Google Scholar
• Sancandi M., Griseri P., Pesce B., Patrone G., Puppo F., Lerone M., et al. Single nucleotide polymorphic alleles in the 5' region of the RET proto‐oncogene define a risk haplotype in Hirschsprung's disease. J Med Genet 2003; 40: 714–8
   Google Scholar
• Borrego S., Wright F. A., Fernandez R. M., Williams N., Lopez‐Alonso M., Davuluri R., et al. A founding locus within the RET proto‐oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma. Am J Hum Genet 2003; 72: 88–100
   Google Scholar
• Garcia‐Barcelo M., Ganster R. W., Lui V. C., Leon T. Y., So M. T., Lau A. M., et al. TTF‐1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease. Hum Mol Genet 2005; 14: 191–204
   Google Scholar
• Griseri P., Bachetti T., Puppo F., Lantieri F., Ravazzolo R., Devoto M., et al. A common haplotype at the 5' end of the RET proto‐oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression. Hum Mutat 2005; 25: 189–95
   Google Scholar
• Burzynski G. M., Nolte I. M., Bronda A., Bos K. K., Osinga J., Plaza Menacho I., et al. Identifying candidate Hirschsprung disease‐associated RET variants. Am J Hum Genet 2005; 76: 850–8
   Google Scholar
• Emison E. S., McCallion A. S., Kashuk C. S., Bush R. T., Grice E., Lin S., et al. A common sex‐dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 2005; 434: 857–63
   PubMed Web of Science ®Google Scholar
• Puppo F., Musso M., Pirulli D., Griseri P., Bachetti T., Crovella S., et al. Comparative genomic sequence analysis coupled to Chromatin Immunoprecipitation: a screening procedure applied to search for regulatory elements at the RET locus. Physiol Genomics 2005; 23: 269–74
   PubMed Web of Science ®Google Scholar